JP2006348055A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006348055A5 JP2006348055A5 JP2006268736A JP2006268736A JP2006348055A5 JP 2006348055 A5 JP2006348055 A5 JP 2006348055A5 JP 2006268736 A JP2006268736 A JP 2006268736A JP 2006268736 A JP2006268736 A JP 2006268736A JP 2006348055 A5 JP2006348055 A5 JP 2006348055A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- salt
- less
- boric acid
- acid derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 8
- 229960001126 alginic acid Drugs 0.000 claims 3
- 235000010443 alginic acid Nutrition 0.000 claims 3
- 229920000615 alginic acid Polymers 0.000 claims 3
- 239000000783 alginic acid Substances 0.000 claims 3
- 150000004781 alginic acids Chemical class 0.000 claims 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims 3
- 239000004327 boric acid Substances 0.000 claims 3
- 238000002360 preparation method Methods 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- 208000002177 Cataract Diseases 0.000 claims 1
- 208000010412 Glaucoma Diseases 0.000 claims 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000003266 anti-allergic effect Effects 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 230000001387 anti-histamine Effects 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- -1 antiallergic Substances 0.000 claims 1
- 239000000739 antihistaminic agent Substances 0.000 claims 1
- 239000013060 biological fluid Substances 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 239000000850 decongestant Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 239000003889 eye drop Substances 0.000 claims 1
- 229940012356 eye drops Drugs 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000003589 local anesthetic agent Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000003547 miosis Effects 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 230000002911 mydriatic effect Effects 0.000 claims 1
- 239000007923 nasal drop Substances 0.000 claims 1
- 229940100662 nasal drops Drugs 0.000 claims 1
- 239000000829 suppository Substances 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006268736A JP2006348055A (ja) | 2001-03-08 | 2006-09-29 | アルギン酸含有組成物 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001064802 | 2001-03-08 | ||
| JP2006268736A JP2006348055A (ja) | 2001-03-08 | 2006-09-29 | アルギン酸含有組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002061761A Division JP3974431B2 (ja) | 2001-03-08 | 2002-03-07 | アルギン酸含有組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006348055A JP2006348055A (ja) | 2006-12-28 |
| JP2006348055A5 true JP2006348055A5 (enExample) | 2008-04-17 |
Family
ID=37644235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006268736A Pending JP2006348055A (ja) | 2001-03-08 | 2006-09-29 | アルギン酸含有組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2006348055A (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008082948A2 (en) * | 2006-12-29 | 2008-07-10 | Bausch & Lomb Incorporated | Ophthalmic alginate composition related methods of manufacture and methods of use |
| JP5258329B2 (ja) * | 2007-06-01 | 2013-08-07 | ロート製薬株式会社 | プラノプロフェン含有水性医薬組成物 |
| JP5620168B2 (ja) * | 2010-06-30 | 2014-11-05 | Ｄｓｐ五協フード＆ケミカル株式会社 | キシログルカン−カチオン複合体及びそれを含有する安定化組成物 |
| JP6213715B2 (ja) * | 2013-06-27 | 2017-10-18 | キョーリンリメディオ株式会社 | 多成分配合点眼剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3601132A1 (de) * | 1986-01-16 | 1987-07-23 | Christian Bannert | Verfahren zur behandlung der schleimhaut |
| CA2044878C (en) * | 1990-08-07 | 2000-12-26 | Tacey X. Viegas | Thermally reversible and irreversible gels |
| JP2001228445A (ja) * | 2000-12-13 | 2001-08-24 | Rohto Pharmaceut Co Ltd | コンタクトレンズ用溶剤 |
-
2006
- 2006-09-29 JP JP2006268736A patent/JP2006348055A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0407845A (pt) | formulação intranasal de rotigotina | |
| JP2016539144A5 (enExample) | ||
| WO2007115039A3 (en) | Multi-cartridge fluid delivery device | |
| NO20085066L (no) | 4,5-difenyl-pyrimidinyl-aminosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
| CA2515293A1 (en) | Eicosapentaenoic acid for use in improving prognosis in the treatment of subarachnoid hemorrhage | |
| ES2802299T3 (es) | Régimen de dosificación para dosis olvidadas para ésteres de paliperidona inyectables de acción prolongada | |
| JP2019147843A (ja) | 吃音を治療するための融合ベンズアゼピン | |
| BRPI0515815B8 (pt) | forma medicamentosa de multipartículas contendo substâncias ativas de ácido nucléico formuladas mucoadesivas, bem como seu processo de preparação | |
| ATE507818T1 (de) | Orale verabreichung eines calcitonins | |
| BRPI0411936A (pt) | composto, processo para a sua preparação, composição farmacêutica que comprende o mesmo, utilização de um composto, métodos para o tratamento e profilaxia de distúrbios do sistema nervoso central, alimentares e obesidade | |
| JP2007238598A5 (enExample) | ||
| JP2006348055A5 (enExample) | ||
| CN105434351B (zh) | 一种复方醋酸氟轻松喷雾剂及其制备方法 | |
| Ozcanli et al. | Sertraline-and mirtazapine-induced severe neutropenia | |
| JP4276841B2 (ja) | 精神病性障害の予防もしくは治療における使用のためのカルバメート化合物 | |
| HRP20120344T1 (hr) | N-(2-hidroksietil)-n-metil-4-(kinolin-8-il(1-(tiazol-4-ilmetil) piperidin-4-iliden)metil)benzamid, postupak njegovog dobivanja kao i njegova uporaba za liječenje bola, tjeskobe i depresije | |
| WO2008157288A3 (en) | A baclofen solution for low-volume therapeutic delivery | |
| ES2323646T3 (es) | Uso de derivados de pirrol contra la ansiedad. | |
| AR043536A1 (es) | Composicion farmaceutica que comprende acido 5-metil-2-(2´-cloro-6´-fluoroanilino)fenilacetico | |
| US20070219201A1 (en) | Combination of atomoxetine and a 5ht1a receptor agonist for treating adhd and other disorders | |
| BRPI0815280A2 (pt) | medicamento que compreende uma formulação líquida aquosa de g-csf, receptáculo para a administração de medicamentos líquidos, seringa ou ampola, kit para a administração parenteral de g-csf | |
| CN103127147A (zh) | 用于治疗鼻部炎症的含有布地奈德和nos抑制剂的药物组合物 | |
| CN201012212Y (zh) | 一种改进的经鼻吸入器 | |
| US7407990B2 (en) | Therapeutic Agents | |
| CN201135685Y (zh) | 鼻腔给药器 |